Drug-eluting stents for infrapopliteal arterial disease in the setting of critical limb ischemia

References

• Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation119(3), e21–e181 (2009).
   PubMed Web of Science ®Google Scholar
• Rosamond W, Flegal K, Furie K et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation117, e25–e146 (2008).
   PubMed Web of Science ®Google Scholar
• Ostchega Y, Paulose-Ram R, Dillon CF et al. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999–2004. J. Am. Geriatr. Soc.55, 583–589 (2007).
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet349(9061), 1269–1276 (1997).
   PubMed Web of Science ®Google Scholar
• Heald CL, Fowkes FG, Murray GD et al. Ankle Brachial Index Collaboration. Risk of mortality and cardiovascular disease associated with the ankle–brachial index: systematic review. Atherosclerosis189, 61–69 (2006).
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Criqui MH, Treat-Jacobson D et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA286, 1317–1324 (2001).
   PubMed Web of Science ®Google Scholar
• Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J. Vasc. Surg.45(Suppl. S), S5–S67 (2007).
   PubMed Web of Science ®Google Scholar
• Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery91, 686–693 (1982).
   PubMed Web of Science ®Google Scholar
• Wolfe JH, Wyatt MG. Critical and subcritical ischaemia. Eur. J. Vasc. Endovasc. Surg.13, 578–582 (1997).
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation113(11), e463–e654 (2006).
   PubMed Web of Science ®Google Scholar
• Adam DJ, Beard JD, Cleveland T et al. Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL): multicentre, randomized controlled trial. Lancet366(9501), 1925–1934 (2005).
   PubMed Web of Science ®Google Scholar
• Jaff M, Cahill K, Yu A, Birnbaum H, Engelhart L. Clinical outcomes and medical care costs among Medicare beneficiaries receiving therapy for peripheral arterial disease. Ann. Vasc. Surg.24, 577–587 (2010).
   PubMed Web of Science ®Google Scholar
• Romiti M, Albers M, Brochado-Neto FC et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J. Vasc. Surg.47, 975–981 (2008).
   PubMed Web of Science ®Google Scholar
• Vogel TR, Dombrovskiy VY, Carson JL, Graham AM. In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia. J. Vasc. Surg.54(1), 109–115 (2011).
   Google Scholar
• Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J. Am. Coll. Cardiol.44, 2307–2314 (2004).
   PubMed Web of Science ®Google Scholar
• Aoki J, Colombo A, Dudek D et al. Persistent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation112(25), 3876–3883 (2005).
   PubMed Web of Science ®Google Scholar
• Grube E, Buellesfeld L. Paclitaxel eluting stents: current clinical experience. Am. J. Cardiovasc. Drugs4(6), 355–360 (2004).
   Google Scholar
• Stettler C, Wandel S, Allemann S et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet370(9591), 937–948 (2007).
   PubMed Web of Science ®Google Scholar
• Rosales OR, Mathewkutty S, Gnaim C. Drug eluting stents for below the knee lesions in patients with critical limb ischemia: long-term follow-up. Catheter Cardiovasc. Interv.72(1), 112–115 (2008).
   Google Scholar
• Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc. Interv.68(5), 793–798 (2006).
   PubMed Web of Science ®Google Scholar
• Balzer JO, Zeller T, Rastan A et al. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents. J. Cardiovasc. Surg.51(2), 183–191 (2010).
   Google Scholar
• Rastan A, Schwarzwalder U, Noory E et al. Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J. Endovasc. Ther.17, 480–487 (2010).
   Google Scholar
• Siablis D, Karnabatidis D, Katsanos K et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J. Vasc. Access20(9), 1141–1150 (2009).
   Google Scholar
• Scheinert D. Achilles study – randomized comparison of Sirolimus eluting stents vs PTA for BTK obstructions. Presented at: The Leipzig Interventional Course. Leipzig, Germany, 19 January 2011.
   Google Scholar
• Zeller T. The Yukon BTK study – final results of the randomized, double blind study of DES vs BMS. Leipzig, Germany. Presented at: The Leipzig Interventional Course. Leipzig, Germany, 19 January 2011.
   Google Scholar
• Bosiers M. DESTINY trial – 12 months clinical and angiographic findings. Presented at: The Leipzig Interventional Course. Leipzig, Germany, 19 January 2011.
   Google Scholar
• Scheinert D, Ulrich M, Scheinert S et al. Comparison of sirolimus-eluting vs bare-metal stents for the treatment of infrapopliteal obstructions. Eurointervention2(2), 169–174 (2006).
   PubMedGoogle Scholar
• Scheinert D. Update: drug-eluting stents in tibial arteries. Endovasc. Today8, 71–74 (2007).
   Google Scholar
• Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (Preventing Amputations Using Drug Eluting Stents) trial. J. Am. Coll. Cardiol.55(15), 1580–1589 (2010).
   PubMed Web of Science ®Google Scholar
• Karnabatidis D, Spiliopoulos S, Diamantopoulos A et al. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J. Endovasc. Ther.18(1), 1–12 (2011).
   PubMed Web of Science ®Google Scholar
• Forbes JF, Adam DJ, Bell J et al. BASIL trial Participants. Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost–effectiveness analysis. J. Vasc. Surg.51(5 Suppl.), S43–S51 (2010).
   PubMed Web of Science ®Google Scholar
• Filion KB, Roy AM, Baboushkin T, Rinfret S, Eisenberg MJ. Cost–effectiveness of drug-eluting stents including the economic impact of late stent thrombosis. Am. J. Cardiol.103(3), 338–344 (2009).
   PubMed Web of Science ®Google Scholar
• Katsanos K. Cost–effectiveness analysis of infrapopliteal drug-eluting stents for critical limb ischemia treatment. Presented at: Society of Interventional Radiology Annual Scientific Meeting. Chicago, IL, USA, 26–31 March 2011.
   Google Scholar